The effects of COVID-19 will likely result in indicators of impairment for many entities, driving an increase in impairment testing. In this reporting update we summarise some of the key impacts of COVID-19 on impairment assessments.
The spread of COVID-19 has seen an unprecedented response by governments, regulators and numerous industry sectors in Australia and around the world. The Australian response to this pandemic has seen the closure of our international and state boarders, significant restrictions on corporate Australia’s ability to operate, volatility and instability in financial markets and significant economic slowdown and uncertainties.
Impairment of non-financial assets is a key area of focus for entities, stakeholders and regulators alike. The effects of COVID-19 will likely cyrstalise indicators of impairment for many entities, driving an increase in impairment testing.
In this Reporting Update we summarise some of the key impacts of COVID-19 on impairment assessments through a series of frequently asked questions. The reporting update covers the following topics:
Refer to the attached Reporting Update to find out more.
If you have any questions, please reach out to your usual KPMG contact.
©2021 KPMG, an Australian partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organisation.
Liability limited by a scheme approved under Professional Standards Legislation.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.